401
|
Abstract
Phagocytosis is a critical host defense mechanism used by macrophages and neutrophils to clear invading pathogens. The complex sequence of events resulting in internalization and degradation of the pathogens is a coordinated process involving lipids, signaling proteins, and the cytoskeleton. Here, we examine the role of the microtubule cytoskeleton in supporting both the engulfment of pathogens and their elimination within phagolysosomes.
Collapse
Affiliation(s)
- Rene E Harrison
- Division of Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada
| | | |
Collapse
|
402
|
Hall AM, Krishnamoorthy L, Orlow SJ. Accumulation of tyrosinase in the endolysosomal compartment is induced by U18666A. PIGMENT CELL RESEARCH 2003; 16:149-58. [PMID: 12622792 DOI: 10.1034/j.1600-0749.2003.00027.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The 3beta-(2-diethylaminoethoxy)-androstenone HCl (U18666A), progesterone and several cationic amphiphilic drugs have been shown to alter the trafficking of a number of intracellular membrane proteins including CD63/Lamp-3, insulin growth factor 2/mannose 6-phosphate receptor (IGF2/MPR), and the Niemann-Pick C1 gene product (NPC1) as well as ganglioside GM1. We have examined the effects of these compounds on cultured melanocytes at concentrations that have been shown to effectively alter intracellular trafficking. Treatment of melanocytes with U18666A (2.5 micro M) or progesterone (15 micro M) for 96 h decreased melanin content an average of 67% as compared with control without lowering the total cellular tyrosinase activity. Steroidal alkaloids that preferentially act on the Sonic Hedgehog signaling pathway showed no related specificity in their ability to decrease pigmentation. In melanocytes treated with U18666A, tyrosinase accumulates in a compartment that contains both lysosome-associated membrane protein-1 (Lamp 1) and MPR, and stains with filipin, consistent with cholesterol-laden late endosomes/lysosomes. Our results suggest that tyrosinase, like the NPC1 gene product, traverses a U18666A-sensitive trafficking pathway.
Collapse
Affiliation(s)
- Andrea M Hall
- The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA
| | | | | |
Collapse
|
403
|
Vieira OV, Bucci C, Harrison RE, Trimble WS, Lanzetti L, Gruenberg J, Schreiber AD, Stahl PD, Grinstein S. Modulation of Rab5 and Rab7 recruitment to phagosomes by phosphatidylinositol 3-kinase. Mol Cell Biol 2003; 23:2501-14. [PMID: 12640132 PMCID: PMC150733 DOI: 10.1128/mcb.23.7.2501-2514.2003] [Citation(s) in RCA: 252] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Phagosomal biogenesis is central for microbial killing and antigen presentation by leukocytes. However, the molecular mechanisms governing phagosome maturation are poorly understood. We analyzed the role and site of action of phosphatidylinositol 3-kinases (PI3K) and of Rab GTPases in maturation using both professional and engineered phagocytes. Rab5, which is recruited rapidly and transiently to the phagosome, was found to be essential for the recruitment of Rab7 and for progression to phagolysosomes. Similarly, functional PI3K is required for successful maturation. Remarkably, inhibition of PI3K did not preclude Rab5 recruitment to phagosomes but instead enhanced and prolonged it. Moreover, in the presence of PI3K inhibitors Rab5 was found to be active, as deduced from measurements of early endosome antigen 1 binding and by photobleaching recovery determinations. Though their ability to fuse with late endosomes and lysosomes was virtually eliminated by wortmannin, phagosomes nevertheless recruited a sizable amount of Rab7. Moreover, Rab7 recruited to phagosomes in the presence of PI3K antagonists retained the ability to bind its effector, Rab7-interacting lysosomal protein, suggesting that it is functionally active. These findings imply that (i) dissociation of Rab5 from phagosomes requires products of PI3K, (ii) PI3K-dependent effectors of Rab5 are not essential for the recruitment of Rab7 by phagosomes, and (iii) recruitment and activation of Rab7 are insufficient to induce fusion of phagosomes with late endosomes and lysosomes. Accordingly, transfection of constitutively active Rab7 did not bypass the block of phagolysosome formation exerted by wortmannin. We propose that Rab5 activates both PI3K-dependent and PI3K-independent effectors that act in parallel to promote phagosome maturation.
Collapse
Affiliation(s)
- Otilia V Vieira
- Cell Biology Program, Hospital for Sick Children and Department of Biochemistry, University of Toronto, Ontario M5G 1X8, Canada
| | | | | | | | | | | | | | | | | |
Collapse
|
404
|
Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, Kwon JM, FitzPatrick D, Schmedding E, De Vriendt E, Jacobs A, Van Gerwen V, Wagner K, Hartung HP, Timmerman V. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72:722-7. [PMID: 12545426 PMCID: PMC1180247 DOI: 10.1086/367847] [Citation(s) in RCA: 389] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2002] [Accepted: 11/25/2002] [Indexed: 01/30/2023] Open
Abstract
Charcot-Marie-Tooth type 2B (CMT2B) is clinically characterized by marked distal muscle weakness and wasting and a high frequency of foot ulcers, infections, and amputations of the toes because of recurrent infections. CMT2B maps to chromosome 3q13-q22. We refined the CMT2B locus to a 2.5-cM region and report two missense mutations (Leu129Phe and Val162Met) in the small GTP-ase late endosomal protein RAB7 which causes the CMT2B phenotype in three extended families and in three patients with a positive family history. The alignment of RAB7 orthologs shows that both missense mutations target highly conserved amino acid residues. RAB7 is ubiquitously expressed, and we found expression in sensory and motor neurons.
Collapse
Affiliation(s)
- Kristien Verhoeven
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Peter De Jonghe
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Katrien Coen
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Nathalie Verpoorten
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Michaela Auer-Grumbach
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Jennifer M. Kwon
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - David FitzPatrick
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Eric Schmedding
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Els De Vriendt
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - An Jacobs
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Veerle Van Gerwen
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Klaus Wagner
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Hans-Peter Hartung
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| | - Vincent Timmerman
- Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp, and Division of Neurology, University Hospital Antwerpen, Antwerp; Institute of Medical Biology and Human Genetics, Karl-Franzens University, Graz, Austria; Department of Neurology, Washington University School of Medicine, St. Louis; South East Scotland Clinical Genetic Service, Western General Hospitals, Edinburgh; Department of Neurology, University Hospital Brussels, Brussels; and Department of Neurology, Heinrich-Heine Universität, Düsseldorf
| |
Collapse
|
405
|
Zhao X, He M, Wan D, Ye Y, He Y, Han L, Guo M, Huang Y, Qin W, Wang MW, Chong W, Chen J, Zhang L, Yang N, Xu B, Wu M, Zuo L, Gu J. The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis. Cancer Lett 2003; 190:221-32. [PMID: 12565177 DOI: 10.1016/s0304-3835(02)00622-5] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Hepatocellular carcinoma (HCC) is one of the most common human cancers in Asia. Previous studies have shown that in addition to aberrations of the p53 gene on chromosome 17p13.1, other gene(s) on chromosome 17p13.3 may also play a role in HCC. To detect the status of loss of heterozygosity (LOH) in HCC and to determine the minimum region of LOH on 17p13.3, we analyzed 22 paired HCC and non-cancerous liver samples with 14 polymorphic markers plus TP53 (p53 gene) as a comparison. The data revealed a high level of LOH (>68%) in a minimum region between D17S1866 and D17S1574, spanning over a 1.5 Mb region. Genomic library screening using markers in the region has resulted in the isolation of a cluster of BAC/PAC clones. We created a physical map in this region. Using large-scale genome sequencing, gene annotation, cDNA screening, and exon trapping, we identified 17 known genes and 13 novel genes in the minimum region. The function of these genes was analyzed and the possibility of several putative tumor suppressor genes was discussed.
Collapse
Affiliation(s)
- Xintai Zhao
- National Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, 2200 Xie Tu Road, 200032, Shanghai, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
406
|
Wallace DME, Lindsay AJ, Hendrick AG, McCaffrey MW. Rab11-FIP4 interacts with Rab11 in a GTP-dependent manner and its overexpression condenses the Rab11 positive compartment in HeLa cells. Biochem Biophys Res Commun 2002; 299:770-9. [PMID: 12470645 DOI: 10.1016/s0006-291x(02)02720-1] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
We have recently identified Rab11-FIP4 as the sixth member of the Rab11-FIP family of Rab11 interacting proteins. Here, we demonstrate that Rab11-FIP4 interacts with Rab11 in a GTP-dependent manner and that its C-terminal region allows the protein to self-interact and interact with pp75/Rip11, Rab11-FIP2, and Rab11-FIP3. However, Rab11-FIP4 does not appear to interact directly with Rab coupling protein (RCP). We investigated the subcellular localisation of Rab11-FIP4 in HeLa cells and show that it colocalises extensively with transferrin and with Rab11. Furthermore, when overexpressed, it causes a condensation of the Rab11 compartment in the perinuclear region. We demonstrate that the carboxy-terminal region of Rab11-FIP4 (Rab11-FIP4(C-ter)) is necessary and sufficient for its endosomal membrane association. Expression of Rab11-FIP4(C-ter) causes a dispersal of the Rab11 compartment towards the cell periphery and does not inhibit transferrin recycling in HeLa cells. It is likely that Rab11-FIP4 serves as a Rab11 effector in a Rab11 mediated function other than transferrin recycling.
Collapse
Affiliation(s)
- Deborah M E Wallace
- Cell and Molecular Biology Laboratory, Department of Biochemistry, University College Cork, Lee Maltings, Prospect Row, Cork, Ireland
| | | | | | | |
Collapse
|
407
|
Wang T, Hong W. Interorganellar regulation of lysosome positioning by the Golgi apparatus through Rab34 interaction with Rab-interacting lysosomal protein. Mol Biol Cell 2002; 13:4317-32. [PMID: 12475955 PMCID: PMC138636 DOI: 10.1091/mbc.e02-05-0280] [Citation(s) in RCA: 103] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
We present evidence to suggest the existence of a regulatory pathway for the Golgi apparatus to modulate the spatial positioning of otherwise distantly located lysosomes. Rab34, a new member of the Rab GTPase family, is associated primarily with the Golgi apparatus. Expression of wild-type or GTP-restricted but not GDP-restricted versions of Rab34 causes spatial redistribution of lysosomes from the periphery to the peri-Golgi region. The regulation of lysosomal positioning by Rab34 depends on its association with the membrane mediated by prenylation and its direct interaction with Rab-interacting lysosomal protein (RILP). This biological activity, mediated by Rab34-RILP interaction, is dependent on Lys82 in the switch I region. Our results have uncovered a novel mechanism for the Golgi apparatus to regulate the spatial distribution of another organelle.
Collapse
Affiliation(s)
- Tuanlao Wang
- Membrane Biology Laboratory, Institute of Molecular and Cell Biology, Singapore 117609, Singapore
| | | |
Collapse
|
408
|
Ghigo E, Capo C, Tung CH, Raoult D, Gorvel JP, Mege JL. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-gamma mediates its restoration and bacterial killing. JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 2002; 169:4488-95. [PMID: 12370385 DOI: 10.4049/jimmunol.169.8.4488] [Citation(s) in RCA: 117] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The subversion of microbicidal functions of macrophages by intracellular pathogens is critical for their survival and pathogenicity. The replication of Coxiella burnetii, the agent of Q fever, in acidic phagolysosomes of nonphagocytic cells has been considered as a paradigm of intracellular life of bacteria. We show in this study that C. burnetii survival in THP-1 monocytes was not related to phagosomal pH because bacterial vacuoles were acidic independently of C. burnetii virulence. In contrast, virulent C. burnetii escapes killing in resting THP-1 cells by preventing phagosome maturation. Indeed, C. burnetii vacuoles did not fuse with lysosomes because they were devoid of cathepsin D, and did not accumulate lysosomal trackers; the acquisition of markers of late endosomes and late endosomes-early lysosomes was conserved. In contrast, avirulent variants of C. burnetii were eliminated by monocytes and their vacuoles accumulated late endosomal and lysosomal markers. The fate of virulent C. burnetii in THP-1 monocytes depends on cell activation. Monocyte activation by IFN-gamma restored C. burnetii killing and phagosome maturation as assessed by colocalization of C. burnetii with active cathepsin D. In addition, when IFN-gamma was added before cell infection, it was able to stimulate C. burnetii killing but it also induced vacuolar alkalinization. These findings suggest that IFN-gamma mediates C. burnetii killing via two distinct mechanisms, phagosome maturation, and phagosome alkalinization. Thus, the tuning of vacuole biogenesis is likely a key part of C. burnetii survival and the pathophysiology of Q fever.
Collapse
Affiliation(s)
- Eric Ghigo
- Unité des Rickettsies, Faculté de Médecine, Centre National de la Recherche Scientifique Unité Mixte de Recherche 6020, Institut Fédératif de Recherche 48, Faculté de Médecine, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 5, France
| | | | | | | | | | | |
Collapse
|
409
|
Vieira OV, Botelho RJ, Grinstein S. Phagosome maturation: aging gracefully. Biochem J 2002; 366:689-704. [PMID: 12061891 PMCID: PMC1222826 DOI: 10.1042/bj20020691] [Citation(s) in RCA: 491] [Impact Index Per Article: 21.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2002] [Revised: 06/05/2002] [Accepted: 06/13/2002] [Indexed: 11/17/2022]
Abstract
Foreign particles and apoptotic bodies are eliminated from the body by phagocytic leucocytes. The initial stage of the elimination process is the internalization of the particles into a plasma membrane-derived vacuole known as the phagosome. Such nascent phagosomes, however, lack the ability to kill pathogens or to degrade the ingested targets. These properties are acquired during the course of phagosomal maturation, a complex sequence of reactions that result in drastic remodelling of the phagosomal membrane and contents. The determinants and consequences of the fusion and fission reactions that underlie phagosomal maturation are the topic of this review.
Collapse
Affiliation(s)
- Otilia V Vieira
- Programme in Cell Biology, Hospital for Sick Children and Department of Biochemistry, University of Toronto, Ontario M5G 1X8, Canada
| | | | | |
Collapse
|
410
|
Wallace DM, Lindsay AJ, Hendrick AG, McCaffrey MW. The novel Rab11-FIP/Rip/RCP family of proteins displays extensive homo- and hetero-interacting abilities. Biochem Biophys Res Commun 2002; 292:909-15. [PMID: 11944901 DOI: 10.1006/bbrc.2002.6736] [Citation(s) in RCA: 69] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The Rab11-FIP/Rip/RCP proteins are a recently described novel protein family, whose members interact with Rab GTPases that function in endosomal recycling. To date, five such proteins have been described in humans, all of which interact with Rab11, and one (RCP) also interacts with Rab4. Here, we characterise several of these proteins with respect to their ability to interact with Rab4, as well as their ability to self-interact, and to interact with each other. We now demonstrate that two of the family members-pp75/Rip11 and Rab11-FIP3 do not bind Rab4 and show that several members of the family can self-interact and interact with each other. These interactions primarily involve their C-terminal end which includes the Rab binding domain (RBD) that is contained within a predicted coiled-coil, or ERM motif. We identify a new (sixth) member of the protein family, which we propose to name Rab11-FIP4, and report the family evolutionary complexity and chromosomal distribution. Furthermore, we propose that the ability of these proteins to bind each other will be important in effecting membrane trafficking events by forming protein 'platforms,' regulated by Rab11 and/or Rab4 activity.
Collapse
Affiliation(s)
- Deborah M Wallace
- Cell and Molecular Biology Laboratory, Department of Biochemistry, University College Cork, Lee Maltings, Prospect Row, Cork, Ireland
| | | | | | | |
Collapse
|
411
|
Monier S, Jollivet F, Janoueix-Lerosey I, Johannes L, Goud B. Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport. Traffic 2002; 3:289-97. [PMID: 11929610 DOI: 10.1034/j.1600-0854.2002.030406.x] [Citation(s) in RCA: 124] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Rab6 GTPase regulates intracellular transport at the level of the Golgi complex. Using the yeast two-hybrid screen, we have isolated two clones that specifically interact with the three isoforms of Rab6 present in mammalian cells (Rab6A, A' and B). The cDNAs encode two proteins of 976 and 1120 amino acids (calculated molecular mass of 112 and 128 kDa, respectively) that we named Rab6IP2A and Rab6IP2B (for Rab6 Interacting Protein 2). The two proteins likely correspond to spliced variants of the same gene. Rab6IP2s have no significant homology with other known proteins, including Rab effectors or partners. They are ubiquitously expressed, mostly cytosolic and found in high molecular mass complexes in brain cytosol. We show that Rab6IP2s can be recruited on Golgi membranes in a Rab6:GTP-dependent manner. The overexpression of any form of Rab6IP2 has no detectable effect on the secretory pathway. In contrast, the retrograde transport of the Shiga toxin B subunit between the plasma membrane and the Golgi complex is partly inhibited in cells overexpressing the Rab6-binding domain of Rab6IP2. Our data suggest that Rab6IP2s is involved in the pathway regulated by Rab6A'.
Collapse
Affiliation(s)
- Solange Monier
- Laboratories Molecular mechanisms of intracellular transport, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, France.
| | | | | | | | | |
Collapse
|
412
|
Lebrand C, Corti M, Goodson H, Cosson P, Cavalli V, Mayran N, Fauré J, Gruenberg J. Late endosome motility depends on lipids via the small GTPase Rab7. EMBO J 2002; 21:1289-300. [PMID: 11889035 PMCID: PMC125356 DOI: 10.1093/emboj/21.6.1289] [Citation(s) in RCA: 264] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
We report that lipids contribute to regulate the bidirectional motility of late endocytic compartments. Late endocytic vesicles loaded with cholesterol lose their dynamic properties, and become essentially immobile, including in cells from Niemann-Pick C patients. These vesicles then retain cytoplasmic dynein activity, but seem to be unable to acquire kinesin activity, eventually leading to paralysis. Our data suggest that this defect depends on the small GTPase Rab7, since the motility of vesicles loaded with cholesterol can be restored by the Rab7 inhibitory mutant N125I. Conversely, wild-type Rab7 overexpression mimics the effects of cholesterol on motility in control cells. Consistently, cholesterol accumulation increases the amounts of membrane-associated Rab7, and inhibits Rab7 membrane extraction by the guanine nucleotide dissociation inhibitor. Our observations thus indicate that cholesterol contributes to regulate the Rab7 cycle, and that Rab7 in turn controls the net movement of late endocytic elements. We conclude that motor functions can be regulated by the membrane lipid composition via the Rab7 cycle.
Collapse
Affiliation(s)
- Cécile Lebrand
- Department of Biochemistry, University of Geneva, Sciences II, Department of Cell Biology, University of Geneva, Sciences III, 30 quai E.Ansermet and Centre Medical Universitaire, Departement de Morphologie, 1 rue Michel Servet, 1211 Geneva 4, Switzerland Present address: University of Notre Dame, Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, Notre Dame, IN 46556-5670, USA Corresponding author e-mail: C.Lebrand and M.Corti contributed equally to this work
| | - Michela Corti
- Department of Biochemistry, University of Geneva, Sciences II, Department of Cell Biology, University of Geneva, Sciences III, 30 quai E.Ansermet and Centre Medical Universitaire, Departement de Morphologie, 1 rue Michel Servet, 1211 Geneva 4, Switzerland Present address: University of Notre Dame, Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, Notre Dame, IN 46556-5670, USA Corresponding author e-mail: C.Lebrand and M.Corti contributed equally to this work
| | - Holly Goodson
- Department of Biochemistry, University of Geneva, Sciences II, Department of Cell Biology, University of Geneva, Sciences III, 30 quai E.Ansermet and Centre Medical Universitaire, Departement de Morphologie, 1 rue Michel Servet, 1211 Geneva 4, Switzerland Present address: University of Notre Dame, Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, Notre Dame, IN 46556-5670, USA Corresponding author e-mail: C.Lebrand and M.Corti contributed equally to this work
| | - Pierre Cosson
- Department of Biochemistry, University of Geneva, Sciences II, Department of Cell Biology, University of Geneva, Sciences III, 30 quai E.Ansermet and Centre Medical Universitaire, Departement de Morphologie, 1 rue Michel Servet, 1211 Geneva 4, Switzerland Present address: University of Notre Dame, Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, Notre Dame, IN 46556-5670, USA Corresponding author e-mail: C.Lebrand and M.Corti contributed equally to this work
| | - Valeria Cavalli
- Department of Biochemistry, University of Geneva, Sciences II, Department of Cell Biology, University of Geneva, Sciences III, 30 quai E.Ansermet and Centre Medical Universitaire, Departement de Morphologie, 1 rue Michel Servet, 1211 Geneva 4, Switzerland Present address: University of Notre Dame, Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, Notre Dame, IN 46556-5670, USA Corresponding author e-mail: C.Lebrand and M.Corti contributed equally to this work
| | - Nathalie Mayran
- Department of Biochemistry, University of Geneva, Sciences II, Department of Cell Biology, University of Geneva, Sciences III, 30 quai E.Ansermet and Centre Medical Universitaire, Departement de Morphologie, 1 rue Michel Servet, 1211 Geneva 4, Switzerland Present address: University of Notre Dame, Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, Notre Dame, IN 46556-5670, USA Corresponding author e-mail: C.Lebrand and M.Corti contributed equally to this work
| | - Julien Fauré
- Department of Biochemistry, University of Geneva, Sciences II, Department of Cell Biology, University of Geneva, Sciences III, 30 quai E.Ansermet and Centre Medical Universitaire, Departement de Morphologie, 1 rue Michel Servet, 1211 Geneva 4, Switzerland Present address: University of Notre Dame, Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, Notre Dame, IN 46556-5670, USA Corresponding author e-mail: C.Lebrand and M.Corti contributed equally to this work
| | - Jean Gruenberg
- Department of Biochemistry, University of Geneva, Sciences II, Department of Cell Biology, University of Geneva, Sciences III, 30 quai E.Ansermet and Centre Medical Universitaire, Departement de Morphologie, 1 rue Michel Servet, 1211 Geneva 4, Switzerland Present address: University of Notre Dame, Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, Notre Dame, IN 46556-5670, USA Corresponding author e-mail: C.Lebrand and M.Corti contributed equally to this work
| |
Collapse
|
413
|
Jordens I, Fernandez-Borja M, Marsman M, Dusseljee S, Janssen L, Calafat J, Janssen H, Wubbolts R, Neefjes J. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol 2001; 11:1680-5. [PMID: 11696325 DOI: 10.1016/s0960-9822(01)00531-0] [Citation(s) in RCA: 650] [Impact Index Per Article: 27.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Many intracellular compartments, including MHC class II-containing lysosomes, melanosomes, and phagosomes, move along microtubules in a bidirectional manner and in a stop-and-go fashion due to the alternating activities of a plus-end directed kinesin motor and a minus-end directed dynein-dynactin motor. It is largely unclear how motor proteins are targeted specifically to different compartments. Rab GTPases recruit and/or activate several proteins involved in membrane fusion and vesicular transport. They associate with specific compartments after activation, which makes Rab GTPases ideal candidates for controlling motor protein binding to specific membranes. We and others [7] have identified a protein, called RILP (for Rab7-interacting lysosomal protein), that interacts with active Rab7 on late endosomes and lysosomes. Here we show that RILP prevents further cycling of Rab7. RILP expression induces the recruitment of functional dynein-dynactin motor complexes to Rab7-containing late endosomes and lysosomes. Consequently, these compartments are transported by these motors toward the minus end of microtubules, effectively inhibiting their transport toward the cell periphery. This signaling cascade may be responsible for timed and selective dynein motor recruitment onto late endosomes and lysosomes.
Collapse
Affiliation(s)
- I Jordens
- Division of Tumour Biology, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands
| | | | | | | | | | | | | | | | | |
Collapse
|
414
|
Bucci C, De Gregorio L, Bruni CB. Expression analysis and chromosomal assignment of PRA1 and RILP genes. Biochem Biophys Res Commun 2001; 286:815-9. [PMID: 11520070 DOI: 10.1006/bbrc.2001.5466] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
PRA1 (prenylated Rab acceptor) is a general regulator of Rab proteins, while RILP (Rab interacting lysosomal protein) is a specific effector for Rab7. It has been shown that PRA1 interacts with Rab proteins and with VAMP2. Therefore PRA1 is probably an important factor for membrane traffic, linking together the function of Rab proteins and SNAREs. RILP has a key role in the control of transport to degradative compartments together with Rab7 and probably links Rab7 function to the cytoskeleton. Here we have studied by Northern blot the expression of the two genes in several different human tissues. The 0.8-kb mRNA for human PRA1 is ubiquitously expressed, while the two mRNAs for RILP are differentially expressed. In addition, we have assigned the human PRA1 gene to chromosome 19q13.13-q13.2 and the human RILP gene to chromosome 17p13.3.
Collapse
Affiliation(s)
- C Bucci
- Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università degli Studi di Lecce, Via Monteroni, 73100 Lecce, Italy.
| | | | | |
Collapse
|
415
|
Caplan S, Hartnell LM, Aguilar RC, Naslavsky N, Bonifacino JS. Human Vam6p promotes lysosome clustering and fusion in vivo. J Cell Biol 2001; 154:109-22. [PMID: 11448994 PMCID: PMC2196876 DOI: 10.1083/jcb.200102142] [Citation(s) in RCA: 124] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
Regulated fusion of mammalian lysosomes is critical to their ability to acquire both internalized and biosynthetic materials. Here, we report the identification of a novel human protein, hVam6p, that promotes lysosome clustering and fusion in vivo. Although hVam6p exhibits homology to the Saccharomyces cerevisiae vacuolar protein sorting gene product Vam6p/Vps39p, the presence of a citron homology (CNH) domain at the NH(2) terminus is unique to the human protein. Overexpression of hVam6p results in massive clustering and fusion of lysosomes and late endosomes into large (2-3 microm) juxtanuclear structures. This effect is reminiscent of that caused by expression of a constitutively activated Rab7. However, hVam6p exerts its effect even in the presence of a dominant-negative Rab7, suggesting that it functions either downstream of, or in parallel to, Rab7. Data from gradient fractionation, two-hybrid, and coimmunoprecipitation analyses suggest that hVam6p is a homooligomer, and that its self-assembly is mediated by a clathrin heavy chain repeat domain in the middle of the protein. Both the CNH and clathrin heavy chain repeat domains are required for induction of lysosome clustering and fusion. This study implicates hVam6p as a mammalian tethering/docking factor characterized with intrinsic ability to promote lysosome fusion in vivo.
Collapse
Affiliation(s)
- S Caplan
- Cell Biology and Metabolism Branch at the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA
| | | | | | | | | |
Collapse
|